APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sclerotherapy

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

Selected research

Market Structure

Global Sclerotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchSclerotherapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sclerotherapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Sclerotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sclerotherapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sclerotherapy Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.

Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.

Read the full market overview

In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.

Report Includes

This report provides an overview of the global Sclerotherapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sclerotherapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sclerotherapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sclerotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Sclerotherapy Segment by Company

BTG

Kreussler

LGM Pharma

Troikaa

Changan Tianyu group

Bioniche Pharma Group Ltd

Omega Pharmaceuticals

Angiodynamics

ENDO-FLEX

MTW ENDOSKOPIE

Cook Medical

Sclerotherapy Segment by Type

Detergents

Osmotic Agents

Chemical Irritants

Sclerotherapy Segment by Application

Venous Disease

Gastrointestinal Bleeding

Bronchopleural Fistula

Cystic Disease

Sclerotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sclerotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sclerotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sclerotherapy industry.

Chapter 3: Detailed analysis of Sclerotherapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sclerotherapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sclerotherapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Detergents Table 3. Key Players of Osmotic Agents Table 4. Key Players of Chemical Irritants Table 4. Global Sclerotherapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Venous Disease Table 6. Key Players of Gastrointestinal Bleeding Table 7. Key Players of Bronchopleural Fistula Table 8. Key Players of Cystic Disease Table 9. Global Sclerotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Sclerotherapy Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Sclerotherapy Market Share by Region (2021-2026) Table 12. Global Sclerotherapy Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Sclerotherapy Market Share by Region (2027-2032) Table 14. Sclerotherapy Industry Trends Table 15. Sclerotherapy Industry Drivers Table 16. Sclerotherapy Industry Opportunities and Challenges Table 17. Sclerotherapy Industry Restraints Table 18. Global Sclerotherapy Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Sclerotherapy Revenue Market Share by Company (2021-2026) Table 20. Global Sclerotherapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Sclerotherapy Key Company Head Office and Area Served Table 22. Global Sclerotherapy Company, Product Type & Application Table 23. Global Sclerotherapy Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Sclerotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Sclerotherapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Sclerotherapy Revenue Market Share by Type (2021-2026) Table 30. Global Sclerotherapy Revenue Market Share by Type (2027-2032) Table 31. Global Sclerotherapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Sclerotherapy Revenue Market Share by Application (2021-2026) Table 35. Global Sclerotherapy Revenue Market Share by Application (2027-2032) Table 36. BTG Company Information Table 37. BTG Business Overview Table 38. BTG Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BTG Sclerotherapy Product Portfolio Table 40. BTG Recent Development Table 41. Kreussler Company Information Table 42. Kreussler Business Overview Table 43. Kreussler Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Kreussler Sclerotherapy Product Portfolio Table 45. Kreussler Recent Development Table 46. LGM Pharma Company Information Table 47. LGM Pharma Business Overview Table 48. LGM Pharma Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. LGM Pharma Sclerotherapy Product Portfolio Table 50. LGM Pharma Recent Development Table 51. Troikaa Company Information Table 52. Troikaa Business Overview Table 53. Troikaa Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Troikaa Sclerotherapy Product Portfolio Table 55. Troikaa Recent Development Table 56. Changan Tianyu group Company Information Table 57. Changan Tianyu group Business Overview Table 58. Changan Tianyu group Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Changan Tianyu group Sclerotherapy Product Portfolio Table 60. Changan Tianyu group Recent Development Table 61. Bioniche Pharma Group Ltd Company Information Table 62. Bioniche Pharma Group Ltd Business Overview Table 63. Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bioniche Pharma Group Ltd Sclerotherapy Product Portfolio Table 65. Bioniche Pharma Group Ltd Recent Development Table 66. Omega Pharmaceuticals Company Information Table 67. Omega Pharmaceuticals Business Overview Table 68. Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Omega Pharmaceuticals Sclerotherapy Product Portfolio Table 70. Omega Pharmaceuticals Recent Development Table 71. Angiodynamics Company Information Table 72. Angiodynamics Business Overview Table 73. Angiodynamics Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Angiodynamics Sclerotherapy Product Portfolio Table 75. Angiodynamics Recent Development Table 76. ENDO-FLEX Company Information Table 77. ENDO-FLEX Business Overview Table 78. ENDO-FLEX Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. ENDO-FLEX Sclerotherapy Product Portfolio Table 80. ENDO-FLEX Recent Development Table 81. MTW ENDOSKOPIE Company Information Table 82. MTW ENDOSKOPIE Business Overview Table 83. MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. MTW ENDOSKOPIE Sclerotherapy Product Portfolio Table 85. MTW ENDOSKOPIE Recent Development Table 86. Cook Medical Company Information Table 87. Cook Medical Business Overview Table 88. Cook Medical Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Cook Medical Sclerotherapy Product Portfolio Table 90. Cook Medical Recent Development Table 91. North America Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 92. North America Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 93. North America Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 94. North America Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 95. North America Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Sclerotherapy Market Size by Country (2021-2026) Table 97. North America Sclerotherapy Market Size by Country (2027-2032) Table 98. Europe Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 99. Europe Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 100. Europe Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 101. Europe Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 102. Europe Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Sclerotherapy Market Size by Country (2021-2026) Table 104. Europe Sclerotherapy Market Size by Country (2027-2032) Table 105. China Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 106. China Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 107. China Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 108. China Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 110. Asia Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 111. Asia Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 112. Asia Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Sclerotherapy Market Size by Country (2021-2026) Table 115. Asia Sclerotherapy Market Size by Country (2027-2032) Table 116. South America, Middle East & Africa Sclerotherapy Market Size by Type (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Sclerotherapy Market Size by Type (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Sclerotherapy Market Size by Application (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Sclerotherapy Market Size by Application (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. South America, Middle East & Africa Sclerotherapy Market Size by Country (2021-2026) Table 122. South America, Middle East & Africa Sclerotherapy Market Size by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Sclerotherapy Product Image Figure 2. Global Sclerotherapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sclerotherapy Market Share by Type: 2025 VS 2032 Figure 4. Detergents Image Figure 5. Osmotic Agents Image Figure 6. Chemical Irritants Image Figure 7. Global Sclerotherapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Sclerotherapy Market Share by Application: 2025 VS 2032 Figure 9. Venous Disease Image Figure 10. Gastrointestinal Bleeding Image Figure 11. Bronchopleural Fistula Image Figure 12. Cystic Disease Image Figure 13. Global Sclerotherapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 15. Global Sclerotherapy Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Sclerotherapy Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Sclerotherapy Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Sclerotherapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Sclerotherapy Revenue Market Share by Type (2021-2032) Figure 22. Global Sclerotherapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sclerotherapy Revenue Market Share by Application (2021-2032) Figure 24. North America Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 25. North America Sclerotherapy Market Share by Type (2021-2032) Figure 26. North America Sclerotherapy Market Share by Application (2021-2032) Figure 27. North America Sclerotherapy Market Share by Country (2021-2032) Figure 28. United States Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 29. Canada Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 32. Europe Sclerotherapy Market Share by Type (2021-2032) Figure 33. Europe Sclerotherapy Market Share by Application (2021-2032) Figure 34. Europe Sclerotherapy Market Share by Country (2021-2032) Figure 35. Germany Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 36. France Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 38. Italy Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 39. Russia Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 41. China Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 42. China Sclerotherapy Market Share by Type (2021-2032) Figure 43. China Sclerotherapy Market Share by Application (2021-2032) Figure 44. Asia Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 45. Asia Sclerotherapy Market Share by Type (2021-2032) Figure 46. Asia Sclerotherapy Market Share by Application (2021-2032) Figure 47. Asia Sclerotherapy Market Share by Country (2021-2032) Figure 48. Japan Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 52. India Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 53. Australia Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Sclerotherapy Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Sclerotherapy Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Sclerotherapy Market Share by Country (2021-2032) Figure 58. Brazil Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 63. UAE Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 65. Chile Sclerotherapy Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
Applications
  • Venous Disease
  • Gastrointestinal Bleeding
  • Bronchopleural Fistula
  • Cystic Disease
Companies covered
  • BTG
  • Kreussler
  • LGM Pharma
  • Troikaa
  • Changan Tianyu group
  • Bioniche Pharma Group Ltd
  • Omega Pharmaceuticals
  • Angiodynamics
  • ENDO-FLEX
  • MTW ENDOSKOPIE
  • Cook Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sclerotherapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Detergents
  5. 1.2.3 Osmotic Agents
  6. 1.2.4 Chemical Irritants
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Sclerotherapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Venous Disease
  10. 1.3.3 Gastrointestinal Bleeding
  11. 1.3.4 Bronchopleural Fistula
  12. 1.3.5 Cystic Disease
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Sclerotherapy Growth Trends by Region
  15. 1.5.1 Global Sclerotherapy Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Sclerotherapy Market Size by Region (2021-2026)
  17. 1.5.3 Sclerotherapy Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Sclerotherapy Market Dynamics
  1. 2.1 Sclerotherapy Industry Trends
  2. 2.2 Sclerotherapy Industry Drivers
  3. 2.3 Sclerotherapy Industry Opportunities and Challenges
  4. 2.4 Sclerotherapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sclerotherapy Revenue by Company (2021-2026)
  2. 3.2 Global Sclerotherapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sclerotherapy Key Company Head office and Area Served
  4. 3.4 Global Sclerotherapy Company, Product Type & Application
  5. 3.5 Global Sclerotherapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sclerotherapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sclerotherapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sclerotherapy Tier 1, Tier 2, and Tier 3
4 Sclerotherapy Market by Type
  1. 4.1 Global Sclerotherapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sclerotherapy Market Size by Type (2021-2032)
  3. 4.3 Global Sclerotherapy Market Size Share by Type (2021-2032)
5 Sclerotherapy Market by Application
  1. 5.1 Global Sclerotherapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sclerotherapy Market Size by Application (2021-2032)
  3. 5.3 Global Sclerotherapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BTG
  2. 6.1.1 BTG Company Information
  3. 6.1.2 BTG Business Overview
  4. 6.1.3 BTG Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BTG Sclerotherapy Product Portfolio
  6. 6.1.5 BTG Recent Developments
  7. 6.2 Kreussler
  8. 6.2.1 Kreussler Company Information
  9. 6.2.2 Kreussler Business Overview
  10. 6.2.3 Kreussler Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Kreussler Sclerotherapy Product Portfolio
  12. 6.2.5 Kreussler Recent Developments
  13. 6.3 LGM Pharma
  14. 6.3.1 LGM Pharma Company Information
  15. 6.3.2 LGM Pharma Business Overview
  16. 6.3.3 LGM Pharma Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 LGM Pharma Sclerotherapy Product Portfolio
  18. 6.3.5 LGM Pharma Recent Developments
  19. 6.4 Troikaa
  20. 6.4.1 Troikaa Company Information
  21. 6.4.2 Troikaa Business Overview
  22. 6.4.3 Troikaa Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Troikaa Sclerotherapy Product Portfolio
  24. 6.4.5 Troikaa Recent Developments
  25. 6.5 Changan Tianyu group
  26. 6.5.1 Changan Tianyu group Company Information
  27. 6.5.2 Changan Tianyu group Business Overview
  28. 6.5.3 Changan Tianyu group Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Changan Tianyu group Sclerotherapy Product Portfolio
  30. 6.5.5 Changan Tianyu group Recent Developments
  31. 6.6 Bioniche Pharma Group Ltd
  32. 6.6.1 Bioniche Pharma Group Ltd Company Information
  33. 6.6.2 Bioniche Pharma Group Ltd Business Overview
  34. 6.6.3 Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bioniche Pharma Group Ltd Sclerotherapy Product Portfolio
  36. 6.6.5 Bioniche Pharma Group Ltd Recent Developments
  37. 6.7 Omega Pharmaceuticals
  38. 6.7.1 Omega Pharmaceuticals Company Information
  39. 6.7.2 Omega Pharmaceuticals Business Overview
  40. 6.7.3 Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Omega Pharmaceuticals Sclerotherapy Product Portfolio
  42. 6.7.5 Omega Pharmaceuticals Recent Developments
  43. 6.8 Angiodynamics
  44. 6.8.1 Angiodynamics Company Information
  45. 6.8.2 Angiodynamics Business Overview
  46. 6.8.3 Angiodynamics Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Angiodynamics Sclerotherapy Product Portfolio
  48. 6.8.5 Angiodynamics Recent Developments
  49. 6.9 ENDO-FLEX
  50. 6.9.1 ENDO-FLEX Company Information
  51. 6.9.2 ENDO-FLEX Business Overview
  52. 6.9.3 ENDO-FLEX Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ENDO-FLEX Sclerotherapy Product Portfolio
  54. 6.9.5 ENDO-FLEX Recent Developments
  55. 6.10 MTW ENDOSKOPIE
  56. 6.10.1 MTW ENDOSKOPIE Company Information
  57. 6.10.2 MTW ENDOSKOPIE Business Overview
  58. 6.10.3 MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 MTW ENDOSKOPIE Sclerotherapy Product Portfolio
  60. 6.10.5 MTW ENDOSKOPIE Recent Developments
  61. 6.11 Cook Medical
  62. 6.11.1 Cook Medical Company Information
  63. 6.11.2 Cook Medical Business Overview
  64. 6.11.3 Cook Medical Sclerotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Cook Medical Sclerotherapy Product Portfolio
  66. 6.11.5 Cook Medical Recent Developments
7 North America
  1. 7.1 North America Sclerotherapy Market Size (2021-2032)
  2. 7.2 North America Sclerotherapy Market Size by Type
  3. 7.2.1 North America Sclerotherapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Sclerotherapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Sclerotherapy Market Share by Type (2021-2032)
  6. 7.3 North America Sclerotherapy Market Size by Application
  7. 7.3.1 North America Sclerotherapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Sclerotherapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Sclerotherapy Market Share by Application (2021-2032)
  10. 7.4 North America Sclerotherapy Market Size by Country
  11. 7.4.1 North America Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sclerotherapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Sclerotherapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Sclerotherapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sclerotherapy Market Size (2021-2032)
  2. 8.2 Europe Sclerotherapy Market Size by Type
  3. 8.2.1 Europe Sclerotherapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sclerotherapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sclerotherapy Market Share by Type (2021-2032)
  6. 8.3 Europe Sclerotherapy Market Size by Application
  7. 8.3.1 Europe Sclerotherapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sclerotherapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sclerotherapy Market Share by Application (2021-2032)
  10. 8.4 Europe Sclerotherapy Market Size by Country
  11. 8.4.1 Europe Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sclerotherapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sclerotherapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sclerotherapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sclerotherapy Market Size (2021-2032)
  2. 9.2 China Sclerotherapy Market Size by Type
  3. 9.2.1 China Sclerotherapy Market Size by Type (2021-2026)
  4. 9.2.2 China Sclerotherapy Market Size by Type (2027-2032)
  5. 9.2.3 China Sclerotherapy Market Share by Type (2021-2032)
  6. 9.3 China Sclerotherapy Market Size by Application
  7. 9.3.1 China Sclerotherapy Market Size by Application (2021-2026)
  8. 9.3.2 China Sclerotherapy Market Size by Application (2027-2032)
  9. 9.3.3 China Sclerotherapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sclerotherapy Market Size (2021-2032)
  2. 10.2 Asia Sclerotherapy Market Size by Type
  3. 10.2.1 Asia Sclerotherapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sclerotherapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sclerotherapy Market Share by Type (2021-2032)
  6. 10.3 Asia Sclerotherapy Market Size by Application
  7. 10.3.1 Asia Sclerotherapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sclerotherapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sclerotherapy Market Share by Application (2021-2032)
  10. 10.4 Asia Sclerotherapy Market Size by Country
  11. 10.4.1 Asia Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sclerotherapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sclerotherapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sclerotherapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sclerotherapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sclerotherapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sclerotherapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sclerotherapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sclerotherapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sclerotherapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sclerotherapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sclerotherapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sclerotherapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sclerotherapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sclerotherapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sclerotherapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sclerotherapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sclerotherapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst